GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Float Percentage Of Total Shares Outstanding

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Float Percentage Of Total Shares Outstanding : 99.90% (As of Jun. 01, 2024)


View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OWC Pharmaceutical Research's float shares is 497.01 Mil. OWC Pharmaceutical Research's total shares outstanding is 497.50 Mil. OWC Pharmaceutical Research's float percentage of total shares outstanding is 99.90%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OWC Pharmaceutical Research's Insider Ownership is 13.87%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OWC Pharmaceutical Research's Institutional Ownership is 0.00%.


OWC Pharmaceutical Research Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

OWC Pharmaceutical Research's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=497.01/497.50
=99.90%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2 Ben Gurion Street, Ramat Gan, ISR, 5257334
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.
Executives
Asher Zwebner director, officer: CHIEF FINANCIAL OFFICER CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387